Heron Therapeutics | HRTX - Le Chiffre D'Affaires De Vente





Ventes Changement Date
ALKERMES USD 392.91M 8.41M 2026-03
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
Amarin USD 49.22M 451K 2025-12
ANI Pharmaceuticals USD 237.5M 9.56M 2026-03
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 73.74M 190.29M 2026-03
Eisai JPY 205.43B 14.51B 2026-03
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Esperion Therapeutics USD 168.45M 81.14M 2025-12
GlaxoSmithKline GBP 7.63B 991M 2026-03
Heron Therapeutics USD 40.59M 2.38M 2025-12
Insmed USD 305.96M 42.16M 2026-03
Ligand Pharmaceuticals USD 51.72M 7.94M 2026-03
Merck USD 16.29B 110M 2026-03
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Neurocrine Biosciences USD 811M 5.5M 2026-03
Pacira USD 177M 19.87M 2026-03
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Surmodics USD 29.57M 355K 2025-06
Ultragenyx Pharmaceutical USD 136M 71M 2026-03
Veracyte USD 139.07M 1.53M 2026-03
Vertex Pharmaceuticals USD 2.99B 200M 2026-03